Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-tyrosine adsorbed for hymenoptera venom
- Development stage
- Unknown
- Lead developer
- ANALLERGO
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
L-tyrosine adsorbed for hymenoptera venom is a subcutaneous allergen extract immunotherapy (SCIT) developed by Anallergo for the treatment of Hymenoptera (insect) venom allergy. The product consists of standardized Hymenoptera venom allergen extracts (such as honeybee, wasp, polistine wasp, and European hornet) adsorbed onto L-tyrosine, which acts as a depot adjuvant carrier. This adsorption provides a slow-release ('retard') mechanism that gradually releases the allergen from the injection site, improving tolerability compared to aqueous formulations. By administering repeated subcutaneous injections of the venom allergen, the therapy induces immune tolerance and desensitizes patients, thereby reducing the risk of systemic anaphylactic reactions upon subsequent insect stings.
- Other names
- L-tyrosine delayed subcutaneous immunotherapy for hymenoptera venomL-tyrosine-adsorbed Hymenoptera venom immunotherapyL-tyrosine-adsorbed subcutaneous specific immunotherapy for hymenoptera venomSCIT L-Tyrosine-Adsorbed
Beyond the preview
Go deeper on L-tyrosine adsorbed for hymenoptera venom.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L-tyrosine adsorbed for hymenoptera venom.